Skip to main content
TipRanks
Go Ultimate75% OFF

Spago Nanomedical AB (SPAGO) Income Statement

1 Followers

Spago Nanomedical AB Income Statement

Last quarter (Q3 2026), Spago Nanomedical AB's total revenue was kr0.00, a decrease of 100.00% from the same quarter last year. In Q3, Spago Nanomedical AB's net income was kr-4.38M. See Spago Nanomedical AB’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
kr 437.00Kkr 1.91Mkr 1.20Mkr 1.05Mkr 660.00K
kr -19.38Mkr -12.36Mkr -23.28Mkr -15.60Mkr -16.78M
kr 11.48Mkr 26.10Mkr 24.49Mkr 25.32Mkr 22.29M
Depreciation and Amortizationkr 167.00Kkr 312.00Kkr 281.00Kkr 356.00Kkr 376.00K
kr -26.39Mkr -33.40Mkr -42.22Mkr -38.73Mkr -38.69M
kr -30.86Mkr -33.71Mkr -47.23Mkr -39.47Mkr -39.19M
kr 4.31Mkr 1.20Mkr 850.00Kkr 268.00Kkr 121.00K
kr -26.55Mkr -32.51Mkr -42.22Mkr -39.20Mkr -39.07M
kr -26.55Mkr -32.51Mkr -42.22Mkr -39.31Mkr -39.08M
Per Share Metrics
Basic EPSkr -0.07kr -0.11kr -0.21kr -0.29kr -0.46
Diluted EPSkr -0.07kr -0.11kr -0.21kr -0.29kr -0.46
Weighted Average Shares Outstanding374.81M295.42M195.96M133.62M83.66M
Weighted Average Shares Outstanding (Diluted)374.81M295.42M195.96M190.43M83.66M

Currency in SEK

Spago Nanomedical AB Earnings and Revenue History

-80M-40M040M-75000 %-50000 %-25000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin